Jan. 23, 2026Financings for Jan. 23, 2026Biopharmas raising money in public or private financings, including: Axogen, Bioage, Corvus, Corxel, Erasca, Mendra, Paq.
Jan. 23, 2026By Tamra SamiCorxel raises $287M series D round to advance oral GLP-1Corxel Pharmaceuticals Ltd. completed a $287 million series D round to advance its lead compound, an oral small-molecule GLP-1 receptor agonist, CX-11, for obese and overweight patients.
Jan. 23, 2026Financings for Jan. 23, 2026Med-tech firms raising money in public or private financings, including: Anteris, Daxor, Medtronic.
